|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash provided by (used in) operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Depreciation in impairment and restructuring | |||||
| Stock-based compensation | |||||
| Change in derivative contracts | |||||
| Non-cash interest expense | |||||
| Loss (gain) on sale of discontinued operations | |||||
| (Gain) loss on sale of assets | |||||
| Insurance proceeds | |||||
| Pension settlement | |||||
| Deferred income taxes | |||||
| Change in other liabilities | |||||
| Cloud-based software implementation costs, net | |||||
| Other - net | |||||
| Changes in working capital: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other working capital | |||||
| Net cash provided by operating activities | |||||
| Cash (used in) provided by investing activities: | |||||
| Capital expenditures | |||||
| Acquisitions | |||||
| Insurance proceeds | |||||
| Sale of assets | |||||
| Sale of business and divestitures | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash provided by (used in) financing activities: | |||||
| Net increase (decrease) in credit facility borrowings | |||||
| Borrowings of credit facility | |||||
| Repayments of credit facility | |||||
| Borrowings of long-term debt | |||||
| Repayments of long-term debt | |||||
| Issuances of Common Stock | |||||
| Repurchases of Common Stock | |||||
| Payment of debt issuance costs | |||||
| Dividends paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Operating cash outflow from operating leases | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Accrued capital expenditures | |||||
| Non-cash consideration for sale of assets and acquisition | |||||
| Supplemental disclosure - Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes | |||||
Loading...